Symptoms and Features of Hordeolum

Clinical Presentation

A hordeolum presents as a painful, erythematous nodule at the eyelid margin with rapid onset and signs of acute inflammation, often with purulent discharge, and is frequently associated with bacterial blepharitis 1
Rapid onset with signs of acute inflammation 2
May have purulent discharge 1
Can occur on either upper or lower eyelid 2
Often associated with bacterial blepharitis 1
Localized swelling and redness 2
Acute inflammatory process with characteristic rapid onset (distinguishing it from chalazion, which has gradual onset) 2, 1

Blepharitis (inflammation of the eyelid margin) is a common predisposing factor 3, 4
Meibomian gland dysfunction may contribute to development 4
History of styes in children is associated with increased risk of developing adult rosacea 4
Systemic conditions like rosacea may predispose to hordeolum development 4, 5
Use of certain medications (e.g., isotretinoin, dupilumab) may increase risk 4
Contact lens wear, particularly with giant papillary conjunctivitis, may be associated with increased risk 4
Components of metabolic syndrome may be associated with higher risk for blepharitis, which predisposes to hordeolum 4

Marked asymmetry, resistance to therapy, or unifocal recurrent lesions 6, 1
Eyelid margin distortion, lash loss (madarosis), or ulceration 2, 1
Unilateral chronic blepharitis unresponsive to therapy 2, 1
Recurrence in the same location, especially in elderly patients (raises suspicion for sebaceous carcinoma) 2, 1

Chalazion: Painless nodule within the tarsal plate with visible meibomian gland obstruction on eyelid eversion, associated with gradual onset 2, 1
Sebaceous carcinoma: May mimic recurrent hordeolum or chalazion, especially in elderly patients 6, 2

Failure to distinguish between hordeolum (acute infection) and chalazion (chronic, non-infectious inflammation) 6
Missing underlying chronic blepharitis that predisposes to recurrent hordeola 6
Overlooking sebaceous carcinoma in cases of recurrent unilateral disease resistant to therapy 6

The American Academy of Ophthalmology recommends aggressive treatment of underlying blepharitis and meibomian gland dysfunction to prevent recurrence of internal hordeolum, with consideration of addressing moderate to severe blepharitis prior to intraocular surgical procedures to reduce risk of postoperative endophthalmitis 7

Azithromycin hydrate ophthalmic solution has demonstrated efficacy in treating internal hordeolum, with complete resolution of inflammatory findings in all treated cases, although this evidence is based on a retrospective case series 7